Skip to main content
lexblog.com/lib/Y227B6HDviewrecordjson
LEX-WK-Y227B6HDcrawled 2023-09-29 15:00Z

Louisiana Fourth Circuit Offers Clarification on the Role of Pharmaceutical Labeling and Package Inserts in Medical Malpractice Litigation: Deviation from manufacturer dosage instructions is not ipso facto evidence of breach

Karen Fontana Young · Louisiana Law Blog · Published April 7, 2014

Work details

firm or organization
Kean Miller
published
2014-04-07

Citation

Karen Fontana Young, Louisiana Fourth Circuit Offers Clarification on the Role of Pharmaceutical Labeling and Package Inserts in Medical Malpractice Litigation: Deviation from manufacturer dosage instructions is not ipso facto evidence of breach, Louisiana Law Blog (April 7, 2014) [The Library at LexBlog, LEX-WK-Y227B6HD, lexpid.org/Y227B6HD]